KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stryker (SYK) Research & Development (2016 - 2025)

Historic Research & Development for Stryker (SYK) over the last 17 years, with Q4 2025 value amounting to $401.0 million.

  • Stryker's Research & Development rose 1201.12% to $401.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 1070.94%. This contributed to the annual value of $1.6 billion for FY2025, which is 1070.94% up from last year.
  • Per Stryker's latest filing, its Research & Development stood at $401.0 million for Q4 2025, which was up 1201.12% from $410.0 million recorded in Q3 2025.
  • Over the past 5 years, Stryker's Research & Development peaked at $413.0 million during Q1 2022, and registered a low of $288.0 million during Q1 2021.
  • For the 5-year period, Stryker's Research & Development averaged around $358.3 million, with its median value being $355.5 million (2023).
  • As far as peak fluctuations go, Stryker's Research & Development surged by 4340.28% in 2022, and later plummeted by 1791.77% in 2023.
  • Over the past 5 years, Stryker's Research & Development (Quarter) stood at $331.0 million in 2021, then decreased by 1.51% to $326.0 million in 2022, then increased by 7.36% to $350.0 million in 2023, then increased by 2.29% to $358.0 million in 2024, then increased by 12.01% to $401.0 million in 2025.
  • Its last three reported values are $401.0 million in Q4 2025, $410.0 million for Q3 2025, and $407.0 million during Q2 2025.